GREAT POINT PARTNERS LLC - Q4 2023 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q4 2023
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STREAMLINE HEALTH SOLUTNS, INC CMN25Q3 20192.5%
IOVANCE BIOTHERAPEUTICS, INC. CMN16Q1 202114.3%
ZOGENIX INC CMN16Q4 20198.8%
PTC THERAPEUTICS, INC. CMN16Q3 20239.9%
EXELIXIS, INC16Q1 20227.5%
SAGE THERAPEUTICS, INC CMN15Q3 202110.8%
CYTOKINETICS INC15Q3 20235.8%
ACADIA PHARMACEUTICALS, INC.14Q1 20218.8%
ACCELERON PHARMA INC CMN14Q2 20208.2%
CONNECTURE INC13Q4 201725.1%

View GREAT POINT PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
GREAT POINT PARTNERS LLC Q4 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
89bio, Inc.February 14, 2023700,0001.4%
KalVista Pharmaceuticals, Inc.February 14, 20231,055,8013.1%
Avalo Therapeutics, Inc.February 13, 2023974,6397.1%
InflaRx N.V.Sold outFebruary 14, 202200.0%
ABEONA THERAPEUTICS INC.Sold outFebruary 16, 202100.0%
CONSTELLATION PHARMACEUTICALS INCFebruary 16, 20211,024,8002.2%
GERON CORPFebruary 16, 202112,754,2284.0%
Millendo Therapeutics, Inc.February 16, 2021270,0001.4%
NextCure, Inc.Sold outFebruary 16, 202100.0%
PROTHENA CORP PUBLIC LTD COFebruary 16, 2021977,6472.4%

View GREAT POINT PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G2024-04-08
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View GREAT POINT PARTNERS LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export GREAT POINT PARTNERS LLC's holdings

CSVXLS